Follow The Filings

BBIO position history

The shares of Bridgebio Pharma (BBIO) that Avidity Partners Management LP reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2023 Q1: 1,000,000 shares, $17M, 0.55% of portfolio, New
  2. 2023 Q2: not held, Exit
  3. 2023 Q3: not held
  4. 2023 Q4: not held
  5. 2024 Q1: not held
  6. 2024 Q2: not held
  7. 2024 Q3: not held
  8. 2024 Q4: not held
  9. 2025 Q1: 75,000 shares, $2.6M, 0.49% of portfolio, New
  10. 2025 Q2: 140,000 shares, $6M, 1.2% of portfolio, Add +86.7%
  11. 2025 Q3: not held, Exit
  12. 2025 Q4: not held
  13. 2026 Q1: 10,000 shares, $711K, 0.16% of portfolio, New
  14. 2026 Q2: 10,000 shares, $745K, 0.12% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders